{
  "REG_COMPANY_ENROL": "Regulatory Company Enrolment",
  "LOAD_COMPANY_FILE": "Load a Company Enrolment File",
//  "ENROL_INSTRUCT": "Company Regulatory Enrolment Instructions",
//  "ADDRESS_INSTRUCT":"Company Address Record Instructions",
//  "ADDRESS_ROLE_INSTRUCT":"Company Address Role Instructions",
  "REPRESENT_INSTRUCT":"Company Representative Information",
//  "SAVE_INSTRUCT": "Company File Save Instructions",
  "AMEND_NOTE": "The “Amend Enrolment” button must be selected when amending a Final Company XML.",
  "FIELDID": "Company Identifier",
  "COMPANY_NAME": "Company Name",
  "HT_LOAD_FILE_1": "A file should not be loaded if this is the first time enrolling the Company.",
  "HT_LOAD_FILE_2": "When continuing with a working copy, the format of the file to load should be .hcsc.",
  "HT_LOAD_FILE_3": "When viewing/updating a final XML file, the format of the file to load should be .xml.",
  "ENROL_1.0": "The “Enrolment Status”, “Enrolment Version”, and “Date Last Saved” fields are automatically filled by the form upon selecting “Save Working Copy” or “Save Draft XML” in the bottom of the template.",
  "ENROL_2.0": "The “Company Identifier” field will be filled by Health Canada when they generate the final company XML file.",
  "ENROL_3.0": "The “Amend Enrolment” button is only enabled when a final company xml file is loaded into the template, and must be selected when amending a final company XML file.",
  "REASON_AMEND_1": "Example:",
  "REASON_AMEND_2": "New company enrolling with REP for the first time",
  "REASON_AMEND_3": "Existing company (company ID# XXXXXXXX)",
  "REASON_AMEND_4": "Amending company information: name change/merger/name change/buyout/identify the significant change to company information.",
  "REASON_AMEND_5": "Other company names that the company may operate under",
  "ADDR_INFO_1": "A minimum of one address is required for the company template.",
  "ADDR_INFO_2.0": "There must be an address associated with each of the following three roles: “Manufacturer / Sponsor Mailing Address”, “Billing Address”, and “Regulatory Mailing / Annual Contact Address”.",
  "ADDR_INFO_3": "A single address may be associated to multiple roles, however, each role may only have one address.",
  "BUS_NUM_4.0": "A business number is a unique, 9-digit number (i.e., the standard identifier for businesses). It is unique to a business or legal entity. Information on the business number can be found on the ",
  "BUS_NUM_4.1": "https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/registering-your-business/you-need-a-business-number-a-program-account.html",
  "BUS_NUM_4.2": "Government of Canada website",
  "ROLE_1": "“Manufacturer / Sponsor Information”: Refers to the name under which the drug submission is filed, where a Drug Identification Number (DIN) / Notice of Compliance (NOC) is to be issued, the company in whose name the DIN / NOC will be registered, and the name to be included on the product label and Product Monograph / Package Insert.",
  "ROLE_2": "For clinical trials: “Sponsor”: Defined by Division 5, Part C of the Food and Drug Regulations as the individual, corporate body, institution or organization that conducts a clinical trial. The sponsor is not necessarily the company that fabricates the drug product. For Investigator-initiated clinical trials: if the sponsor is defined as an individual, please also indicate the name of the affiliated institution/organization.",
  "ROLE_3": "“Regulatory Mailing / Annual Contact Address”: Pertains to where and to whom Health Canada should direct regulatory mail other than correspondence specific to the subject drug submission, e.g. annual notification, regulatory / policy amendment notices as they apply to DINs registered to the manufacturer/sponsor. Operational and system requirements dictate that the regulatory mailing name/address must be the same for all DINs registered to the manufacturer / sponsor identified where more than one DIN is held by that company.",
  "ROLE_4": "“Billing Address” – To whom the invoice is to be sent.",
//  "ROLE_5": "“Canadian Importer mailing address”: is responsible for the sale of products in Canada when the sponsor/manufacturer identified is NOT located in Canada.  Although it does not need to be provided at the time of initial company enrolment, the Canadian Importer responsible for sale must be identified prior to the product entering the market. Add a Canadian Importer Mailing Address to the Company XML file by using the “amend enrolment” button. The Importer Company ID issued by Health Canada should also be referred to in the Product Information XML file, where appropriate.",
//  "ROLE_6": "The Canadian Importer Mailing Address role is used to identify a company that is importing products on behalf of the manufacturer in cases where the manufacturer/sponsor is not located in Canada. If they (i.e. the manufacturer/sponsor ) are located in Canada, then a designated importer is not required.",
//  "ROLE_6": "Do Not provide a Canadian Importer for clinical trial transactions on the company template. Importer information related to clinical trial regulatory activities should be authorized by the sponsor and captured on the Product Information (PI) template and a separate authorization letter. ",
//  "ROLE_7": "For clinical trials: Do not identify importers related to clinical trials on the Company (CO) template. Importer information related to clinical trials should be captured on the Product Information (PI) template.",
  "COMPANY_REP_1": "A minimum of one company representative is required for the company template.",
  "COMPANY_REP_2": "There must be a company representative associated with each of the following roles: “Manufacturer / Sponsor Mailing Address”, “Billing Address”, “Regulatory Mailing / Annual Contact” and “REP contact”.",
  "COMPANY_REP_3": "A single contact may be associated with multiple roles, however, each role may only have one contact.",
  "COMPANY_REP_4": "The REP contact is the person to be contacted by Health Canada if there are any issues or clarifications required for this template when it is submitted for enrolment or amendment.",
  "COMPANY_REP_5": "One company representative is required for each Canadian Importer Mailing Address that has been provided",
//  "COMPANY_REP_5": "Sponsors may choose to provide an Alternate REP contact, however this is not a requirement.",
//  "COMPANY_REP_6": "Description of Roles",
//  "COMPANY_REP_7": "“Manufacturer / Sponsor Information”: Refers to the name under which the drug submission is filed, where a Drug Identification Number (DIN) / Notice of Compliance (NOC) is to be issued, the company in whose name the DIN / NOC will be registered, and the name to be included on the product label and Product Monograph / Package Insert.",
//  "COMPANY_REP_8": "For clinical trials: “Sponsor”: Defined by Division 5, Part C of the Food and Drug Regulations as the individual, corporate body, institution or organization that conducts a clinical trial. The sponsor is not necessarily the company that fabricates the drug product. For Investigator-initiated clinical trials: if the sponsor is defined as an individual, please also indicate the name of the affiliated institution/organization.",
//  "COMPANY_REP_9": "“Regulatory Mailing / Annual Contact”: pertains to where and to whom Health Canada should direct regulatory mail other than correspondence specific to the subject drug submission, e.g. annual notification, regulatory / policy amendment notices as they apply to DINs registered to the manufacturer/sponsor. Operational and system requirements dictate that the regulatory mailing name/address must be the same for all DINs registered to the manufacturer / sponsor identified where more than one DIN is held by that company.",
//  "COMPANY_REP_10": "“Billing Address” – To whom the invoice is to be sent.",
  "ROUTING_ID_1": "The routing identifier is a unique identifier within the Common Electronic Submissions Gateway (CESG) used to identify specific gateway account, whether it uses the Applicability Statement 2 (AS2) or WebTrader interfaces.",
  "ROUTING_ID_2": "For the WebTrader users, the routing identifier is automatically assigned to each account by the system. It can be retrieved from the receipt message. Navigate to the WebTrader Inbox, click on “Receipt”, “View” document. Document Content page opens up and the routing identifier can be found under attribute: “X-Cyclone-To:”",
  "ROUTING_ID_3": "For the AS2 users, the routing identifier has to be created by the company. It is recommended that the company's data universal numbering system number be used, but any alpha-numeric text string is acceptable.",
  "ROUTING_ID_4.0": "For any further questions on the routing identifier, please contact the Food and Drug Administration Help Desk at ",
  "ROUTING_ID_4.1": "mailto:ESGHelpDesk@fda.hhs.gov",
  "ROUTING_ID_4.2": "ESGHelpDesk@fda.hhs.gov",
  "ROUTING_ID_5": "The routing identifier could be the same for the manufacturer / sponsor contact and regulatory / annual contact. The Canadian importer would have a separate routing identifier.",
//  "COMPANY_ROLE_1": "The Primary Regulatory Enrolment Process (REP) contact is the person to be contacted by Health Canada if there are any issues or clarifications required for this template when it is submitted for enrolment or amendment.",
  "GEN_XML_1": "Submit the draft XML file to Health Canada using the Common Electronic Submission Gateway (CESG).",
  "GEN_XML_2": "Refer to the Regulatory Enrolment Process (REP) guidance document for detailed information."
}